CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

You are here

Products

Products

back to search results

MUC4 [8G7]

Product information References Bioinformatics Documents
Product group: Primary
Monoclonal/ Polyclonal: Monoclonal
Clone: 8G7
Host: Mouse
Isotype: IgG1
Application: Immunofluorescence (IF), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blot (WB)
Application notes: 50-200
Conjugation Type: Unconjugated
Lightchain type: Kappa
Reactivity: Human
General notes: Localization: cytoplasm, membrane.
Buffer: EDTA pH8.0
UNSPSC code: 12352203

MUC4 is a high molecular weight glycoprotein that plays an important role in cell proliferation and differentiation of epithelial cells. The MUC4 gene is expressed in various normal epithelial tissues of endodermic origin and carcinomas derived from these tissues. MUC4 antibody labels normal epithelial cells in the trachea, GI tract and prostate, but not in the pancreas. Increased expression of MUC4 has been observed in pancreatic carcinoma and cervical squamous carcinoma. MUC4 is helpful in differentiating lung adenocarcinoma (positive) from malignant mesothelioma (negative). Additionally, MUC4 is useful in the identification of low-grade fibromyxoid sarcoma (LGFMS), and sclerosing epithelioid fibrosarcoma. (Shipping Cost: €200.00)

MUC4 [8G7]

MUC4 is a high molecular weight glycoprotein that plays an important role in cell proliferation and differentiation of epithelial cells. The MUC4 gene is expressed in various normal epithelial tissues of endodermic origin and carcinomas derived from these tissues. MUC4 antibody labels normal epithelial cells in the trachea, GI tract and prostate, but not in the pancreas. Increased expression of MUC4 has been observed in pancreatic carcinoma and cervical squamous carcinoma. MUC4 is helpful in differentiating lung adenocarcinoma (positive) from malignant mesothelioma (negative). Additionally, MUC4 is useful in the identification of low-grade fibromyxoid sarcoma (LGFMS), and sclerosing epithelioid fibrosarcoma.